Clinical trial / 2014
Flaxseed lowered blood pressure in patients with peripheral arterial disease.
In a randomized double-blind trial, patients with peripheral arterial disease consumed 30 grams of milled flaxseed daily or control for six months. Flaxseed consumption reduced systolic blood pressure by 10 mm Hg and diastolic blood pressure by 7 mm Hg while altering circulating oxylipins. Participants exhibiting reductions in soluble epoxide hydrolase-derived oxylipins had significant decreases in systolic blood pressure (mean -7.97 mm Hg, 95% CI -14.4 to -1.50).
- Study type
- Randomized controlled trial
- Who was studied
- Adults with peripheral arterial disease (75% hypertensive)
- What was measured
- Blood pressure and plasma oxylipins
THE PAPER
Flaxseed consumption reduces blood pressure in patients with hypertension by altering circulating oxylipins via an α-linolenic acid-induced inhibition of soluble epoxide hydrolase.
Caligiuri SP, Aukema HM, Ravandi A, Guzman R, Dibrov E, Pierce GN. Hypertension, 2014.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.